Zinc Oxide in Children's and Sensitive Skin Sunscreen: Why the Active Ingredient Matters

Advance ZincTek Team

1 day ago

5 min read

Executive summary

Zinc oxide is a natural mineral UV filter providing broad-spectrum photoprotection across both UVA and UVB; it sits on the surface of the skin rather than being absorbed into it.
It is photostable, anti-inflammatory and naturally antimicrobial, and is placed in Category I in the FDA's proposed sunscreen monograph, meaning the record supports a determination that it is generally recognised as safe and effective; that order remains in proposed form.
Infant skin and reactive, eczema-prone or rosacea-prone skin share a more permeable, easily challenged barrier, which is why the American Academy of Dermatology, the American Academy of Pediatrics, the National Eczema Association and the British Association of Dermatologists each identify mineral filters, including zinc oxide, in their published guidance for these groups.
Because it works at the surface rather than needing to be absorbed, zinc oxide is active immediately on application and does not present the absorption route associated with contact sensitisation to organic filters.
One chemical filter still permitted in Australia at up to 4 per cent, 4-MBC, has been prohibited, restricted or never permitted in 109 jurisdictions elsewhere, including the EU, UK, US and Japan, over endocrine-disrupting concerns; fragrance is a separate, commonly implicated trigger in sunscreen-related contact dermatitis.
For infants under six months, the FDA and the American Academy of Pediatrics advise shade, clothing and hats rather than routine sunscreen use, whatever the filter.

The skin that needs the most care

Infant skin is thinner than adult skin, with a less developed barrier, making it more permeable and more vulnerable to UV damage and irritation. Reactive, eczema-prone and rosacea-prone skin operates the same way: the barrier is already compromised, and the skin is quicker to react to anything that challenges it. For both groups, what goes into a sunscreen matters as much as what it protects against. Chemical UV filters are absorbed into the upper layers of the skin in order to work, whereas mineral filters act at the surface. Contact and photocontact allergy to individual organic filters is documented in the dermatological literature (Mahajan et al., 2024); reaction rates vary by filter and by formulation.

How zinc oxide works, and why it is different

Zinc oxide is a mineral filter. Rather than absorbing UV and dissipating it as heat within the skin, it attenuates UV radiation at the surface, without needing to penetrate skin layers. It is active immediately on application, which matters practically for children where a fifteen-minute wait before sun exposure is rarely realistic. Because it does not need to be absorbed to become effective, it does not present the absorption route associated with contact sensitisation to organic filters.

Properties that go beyond UV filtration

Zinc oxide has well-documented anti-inflammatory properties, which is why it has been a mainstay of barrier and nappy creams for decades. It has a calming effect on reactive skin conditions including eczema and rosacea, and is one of the few UV actives that may actively support skin health rather than simply screen it (Lansdown, 2007). It is also antimicrobial and photostable. Photostability means it retains its measured photoprotective performance under sustained UV exposure rather than degrading during wear (Herzog et al., 2004). Its coverage spans UVB, UVA2 and UVA1; zinc oxide is the only mineral UV filter that independently achieves true broad-spectrum protection, including deep UVA1 wavelengths, without requiring combination with another active ingredient (Beasley and Meyer, 2010).

Chemical filters and 4-MBC

Not all chemical UV filters carry the same regulatory standing. Oxybenzone, avobenzone and octocrylene are among the most common. One filter still permitted in Australia at up to 4 per cent, 4-methylbenzylidene camphor (4-MBC, enzacamene), has been prohibited, restricted or never permitted in 109 jurisdictions on the Australian Sunscreen Council's count, including the EU, the UK, the US and Japan. The European Commission's Scientific Committee on Consumer Safety was unable to conclude on the safety of 4-MBC and found that use at 4 per cent would not be safe, citing endocrine-disrupting activity, dermal absorption and insufficient genotoxicity data (SCCS/1640/21, 2022). It has been measured in human milk in a study associating the finding with maternal use of UV-filter-containing products (Schlumpf et al., 2010). The TGA's review of 4-MBC is open and no recommendation has been published (TGA, 2026). Fragrance, separately, is one of the most commonly implicated triggers in sunscreen-related contact dermatitis, particularly in reactive and sensitive skin (Mahajan et al., 2024), and is frequently present in the same formulations.

What the ingredient list reflects

When selecting a sunscreen, the active ingredient listed on the back of the pack identifies the UV filter. Zinc oxide, ideally described as non-nano, indicates a mineral filter working at the skin surface without absorption. Fragrance is worth checking separately: even in formulas marketed as gentle, it is one of the most frequently implicated triggers in sunscreen-related contact dermatitis for sensitive and reactive skin (Mahajan et al., 2024).

Technical summary

Zinc oxide is a mineral, broad-spectrum UV filter covering UVB, UVA2 and UVA1. In the FDA’s proposed sunscreen monograph, zinc oxide is placed in Category I at concentrations up to 25 per cent; that order remains in proposed form (FDA, 2021). It is photostable, retaining measured photoprotective performance under sustained UV exposure (Herzog et al., 2004). Zinc oxide is the only mineral UV filter that independently achieves true broad-spectrum protection, including deep UVA1 wavelengths, without requiring combination with another active ingredient (Beasley and Meyer, 2010).

Zinc oxide nanoparticle formulations have been reported not to penetrate into viable skin tissue or enter systemic circulation after repeated application (Mohammed et al., 2019); dedicated skin-penetration data for non-nano zinc oxide specifically has not been cited here. It has documented anti-inflammatory properties (Lansdown, 2007) and antimicrobial activity through zinc ion release (Sirelkhatim et al., 2015).

The American Academy of Dermatology, the American Academy of Pediatrics, the National Eczema Association and the British Association of Dermatologists each identify mineral filters, including zinc oxide, in their published guidance for children and for skin affected by eczema and rosacea. For infants under six months, the FDA and the American Academy of Pediatrics advise shade, clothing and hats rather than routine sunscreen use, irrespective of filter type. Sunscreen is one component of sun protection alongside shade, clothing, hats and avoiding prolonged high-risk sun exposure, and requires frequent reapplication in accordance with the directions for use to be effective.

References

FDA. (2021). Sunscreen drug products for over-the-counter human use. U.S. Food and Drug Administration. federalregister.gov

Beasley, D. G., & Meyer, T. A. (2010). Characterization of the UVA protection provided by avobenzone, zinc oxide, and titanium dioxide in broad-spectrum sunscreen products. American Journal of Clinical Dermatology, 11(6), 413-421.

Herzog, B., Wehrle, M., & Quass, K. (2004). Photostability of UV absorber systems in sunscreens. Photochemistry and Photobiology, 79(4), 391-397.

Lansdown, A. B. G. (2007). Zinc in wound healing: Theoretical, experimental, and clinical aspects. Wound Repair and Regeneration, 15(1), 2-16.

Mahajan, V. K., et al. (2024). Topical sunscreens: A narrative review for contact sensitivity, potential allergens, clinical evaluation, and management. Indian Dermatology Online Journal, 15(6), 920-929.

Mohammed, Y. H., et al. (2019). Support for the safe use of zinc oxide nanoparticle sunscreens: Lack of skin penetration or cellular toxicity after repeated application in volunteers. Journal of Investigative Dermatology, 139(2), 308-315.

SCCS. (2022). Opinion on 4-Methylbenzylidene camphor (4-MBC) (SCCS/1640/21). European Commission, Scientific Committee on Consumer Safety.

Sirelkhatim, A., et al. (2015). Review on zinc oxide nanoparticles: Antibacterial activity and toxicity mechanism. Nano-Micro Letters, 7(3), 219-242.